Risk of Recurrence after Surgical Resection for Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasia (IPMN) with Patterns of Distribution and Treatment: An International, Multicentre, Observational Study.

James Lucocq, Jake Hawkyard,Francis P Robertson, Beate Haugk, Jonathan Lye, Daniel Parkinson,Steve White, Omar Mownah, Yoh Zen,Krishna Menon,Takaaki Furukawa,Yosuke Inoue,Yuki Hirose,Naoki Sasahira,Michael Feretis,Anita Balakrishnan,Piotr Zelga,Carlo Ceresa,Brian Davidson,Rupaly Pande,Bobby Dasari,Lulu Tanno,Dimitrios Karavias,Jack Helliwell, Alistair Young, Quentin Nunes, Tomas Urbonas,Michael Silva,Alex Gordon-Weeks,Jenifer Barrie,Dhanny Gomez, Stijn van Laarhoven,Joseph Doyle,Ricky Bhogal,Ewen Harrison,Marcus Roalso,Debora Ciprani,Somaiah Aroori,Bathiya Ratnayake,Jonathan Koea,Gabriele Capurso,Ruben Bellotti,Stefan Stättner, Tareq Alsaoudi,Neil Bhardwaj, Fraser Jeffery,Saxon Connor,Andrew Cameron,Nigel Jamieson,Amy Sheen,Anubhav Mittal, Jas Samra,Anthony Gill,Keith Roberts,Kjetil Soreide,Sanjay Pandanaboyana

Annals of surgery（2023）

引用 0|浏览33

暂无评分

摘要

Recurrence after pancreatic resection for adenocarcinoma arising from IPMN is frequent with a quarter of patients recurring within 12 months. Treatment of recurrence is associated with improved overall survival and should be considered.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要